Similar articles

• Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps.

  Garraud O, Burnouf T. Garraud O, et al. Transfus Clin Biol. 2021 Aug;28(3):225-227. doi: 10.1016/j.tracli.2021.07.005. Transfus Clin Biol. 2021. PMID: 34362557 Free PMC article. No abstract available.
• COVID-19 Pandemic and Virtual Clinics for Diabetes Care.

  Garg SK, Reinicke T. Garg SK, et al. Diabetes Technol Ther. 2021 Jun;23(S2):S3-S15. doi: 10.1089/dia.2021.2501. Diabetes Technol Ther. 2021. PMID: 34061640 Review. No abstract available.
• New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic.

  Seghatchian J. Seghatchian J. Transfus Apher Sci. 2021 Feb;60(1):103051. doi: 10.1016/j.transci.2021.103051. Epub 2021 Jan 11. Transfus Apher Sci. 2021. PMID: 33461918 Free PMC article. No abstract available.
• Beyond vascular surgery: a general overview from the web.

  Spada P, Silvestri G. Spada P, et al. J Cardiovasc Surg (Torino). 2021 Dec;62(6):571-572. doi: 10.23736/S0021-9509.21.12000-2. Epub 2021 Sep 30. J Cardiovasc Surg (Torino). 2021. PMID: 34590810 No abstract available.
• COVID-19: benefits and risks of passive immunotherapeutics.

  Gupta A, Karki R, Dandu HR, Dhama K, Bhatt ML, Saxena SK. Gupta A, et al. Hum Vaccin Immunother. 2020 Dec 1;16(12):2963-2972. doi: 10.1080/21645515.2020.1808410. Epub 2020 Sep 22. Hum Vaccin Immunother. 2020. PMID: 32962524 Free PMC article. Review.